[PUBLICATION] Trans ε-Viniferin Decreases Amyloid Deposits With Greater Efficiency Than Resveratrol in an Alzheimer’s Mouse Model

  • Recherche,
  • Santé-Sciences-Technologie,
Alzheimer Disease
Alzheimer Disease

du 12 janvier 2022 au 19 janvier 2022

Collaborative research project led by Prof. Page (EA3808 Neurovascular Unit and Cognitive Disorders, University of Poitiers, Poitiers, France) in which Drs. Chalon, Galineau, Tauber and Serrière participated.

 / 1
Contact :
Dr. Sylvie Chalon :